Jabra Enhance Select 700 vs Signia Pure C&G IX

The Jabra Enhance Select 700 is a premium-priced OTC hearing aid available at $1,795, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This behind-the-ear device ranks #26 of 65 OTC hearing aids tested, placing it in the top 38% of the category. In our testing, the Enhance Select 700 shows notable strengths in own-voice comfort, scoring 3.7/5—a solid result that sits 1.19 points above the category average. This makes it a comfortable choice for users sensitive to the "hollow" sound of their own voice that some hearing aids produce. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during typical daily activities. Speech clarity in quiet environments is solid at 3.1/5, coming in 0.27 points above the category average. However, speech understanding in noisy settings is a weakness, scoring just 1.0/5—falling 0.48 points below the category average. Users who frequently encounter restaurants, group gatherings, or other challenging listening environments may find this limitation significant. Music streaming quality is mixed at 2.5/5, though still 0.58 points above the category average. At this price point, buyers should note that several same-priced alternatives deliver stronger overall performance, including the Lucid Tala (4.63/5) and Audicus Omni 2 (4.61/5). The Enhance Select 700 is best suited for users who prioritize own-voice comfort and feedback-free wear over speech-in-noise performance, and who value Jabra's established brand and support ecosystem.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.